Home World News Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell Anal... World News Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell Anal Cancer By Ogkologos - July 15, 2025 826 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the POD1UM-303/InterAACT-2 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR EMA Recommends Extension of Therapeutic Indications for Cetuximab August 14, 2026 FDA Approves Asciminib for Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia November 3, 2021 FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung... July 25, 2025 Coronavirus reports – Part 6 “The kids being home all the... July 17, 2020 Load more HOT NEWS FDA Grants Traditional Approval to Selpercatinib for RET Fusion-positive Thyroid Cancer The future of dMMR/MSI-H locally advanced rectal cancer could be free... Study Suggests Watching Disney Movies May Improve Quality of Life for... People With Certain Cancers Are Almost Three Times As Likely To...
